257 related articles for article (PubMed ID: 32321435)
1. Burden of HPV related anogenital diseases in young women in Germany - an analysis of German statutory health insurance claims data from 2012 to 2017.
Reuschenbach M; Mihm S; Wölle R; Schneider KM; Jacob C; Braun S; Greiner W; Hampl M
BMC Infect Dis; 2020 Apr; 20(1):297. PubMed ID: 32321435
[TBL] [Abstract][Full Text] [Related]
2. Healthcare resource utilization and costs in 23-25-year-old women with human papillomavirus (HPV) associated anogenital diseases in Germany - a retrospective analysis of statutory health insurance claims data.
Reuschenbach M; Mihm S; Wölle R; Schneider KM; Jacob C; Greiner W; Hampl M; Goodman E
BMC Health Serv Res; 2022 Aug; 22(1):1002. PubMed ID: 35932066
[TBL] [Abstract][Full Text] [Related]
3. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.
Drolet M; Bénard É; Pérez N; Brisson M;
Lancet; 2019 Aug; 394(10197):497-509. PubMed ID: 31255301
[TBL] [Abstract][Full Text] [Related]
4. HPV vaccination leads to decrease of anogenital warts and precancerous lesions of the cervix uteri in young women with low vaccination rates: a retrospective cohort analysis.
Osmani V; Fett S; Tauscher M; Donnachie E; Schneider A; Klug SJ
BMC Cancer; 2022 Dec; 22(1):1293. PubMed ID: 36494790
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Cervico-vaginal High-risk HPV Types and Other Sexually Transmitted Pathogens in Anogenital Warts Patients.
Mortaki D; Tsitsopoulos E; Louizou E; Tsiambas E; Peschos D; Sioulas V; Galanos A; Tagka A; Gregoriou S; Stratigos A; Rigopoulos D; Nicolaidou E
Anticancer Res; 2020 Apr; 40(4):2219-2223. PubMed ID: 32234917
[TBL] [Abstract][Full Text] [Related]
6. Estimates of the timing of reductions in genital warts and high grade cervical intraepithelial neoplasia after onset of human papillomavirus (HPV) vaccination in the United States.
Chesson HW; Ekwueme DU; Saraiya M; Dunne EF; Markowitz LE
Vaccine; 2013 Aug; 31(37):3899-905. PubMed ID: 23820080
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of human papillomavirus-related diseases in the Republic of Korea: a cross-sectional study.
Oh JK; Choi HY; Han M; Lee JK; Min KJ; Ki M
Sex Transm Infect; 2019 Jun; 95(4):292-299. PubMed ID: 30679392
[TBL] [Abstract][Full Text] [Related]
8. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
Muñoz N; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia PJ; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Huh WK; Joura EA; Kurman RJ; Majewski S; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Lupinacci LC; Giacoletti KE; Sings HL; James MK; Hesley TM; Barr E; Haupt RM
J Natl Cancer Inst; 2010 Mar; 102(5):325-39. PubMed ID: 20139221
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of genital HPV infection among long-term monogamous partners of women with cervical dysplasia or genital warts-Another reason for HPV vaccination of boys.
Rob F; Tachezy R; Pichlík T; Rob L; Kružicová Z; Hamšíková E; Šmahelová J; Hercogová J
Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27723194
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of anogenital warts and cancer.
Franco EL
Obstet Gynecol Clin North Am; 1996 Sep; 23(3):597-623. PubMed ID: 8869948
[TBL] [Abstract][Full Text] [Related]
11. [Physiopathology and epidemiology of HPV anogenital diseases].
Riethmuller D
Ann Dermatol Venereol; 2000; 127(10 Suppl):3S5-3S9. PubMed ID: 11116862
[No Abstract] [Full Text] [Related]
12. Spectrum of genital human papillomavirus infection in a female adolescent population.
Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
[TBL] [Abstract][Full Text] [Related]
13. Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis.
Denecke A; Iftner T; Iftner A; Riedle S; Ocak M; Luyten A; Üye I; Tunc K; Petry KU
BMC Infect Dis; 2021 Jul; 21(1):634. PubMed ID: 34215215
[TBL] [Abstract][Full Text] [Related]
14. Trends in the Prevalence of Anogenital Warts Among Patients at Sexually Transmitted Disease Clinics-Sexually Transmitted Disease Surveillance Network, United States, 2010-2016.
Mann LM; Llata E; Flagg EW; Hong J; Asbel L; Carlos-Henderson J; Kerani RP; Kohn R; Pathela P; Schumacher C; Torrone EA
J Infect Dis; 2019 Apr; 219(9):1389-1397. PubMed ID: 30500908
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the prevalence of human papillomavirus and abnormal anal cytology in women at risk.
Lopez-Cavanillas B; G Benitez C; Serrano M; Sendagorta E; Hernandez A; Bartha JL
J Obstet Gynaecol; 2021 Oct; 41(7):1139-1144. PubMed ID: 33459109
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of human papillomavirus on anogenital warts in Portugal - The HERCOLES study.
Azevedo J; Pista A; Lisboa C; Santo I; Azevedo L; Cunha MJ;
J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):1342-1348. PubMed ID: 28485812
[TBL] [Abstract][Full Text] [Related]
17. Health and economic burden of HPV-related diseases in Singapore.
Low JJ; Ko Y; Ilancheran A; Zhang XH; Singhal PK; Tay SK
Asian Pac J Cancer Prev; 2012; 13(1):305-8. PubMed ID: 22502690
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus DNA and mRNA positivity of the anal canal in women with lower genital tract HPV lesions: predictors and clinical implications.
Valari O; Koliopoulos G; Karakitsos P; Valasoulis G; Founta C; Godevenos D; Dova L; Paschopoulos M; Loufopoulos A; Paraskevaidis E
Gynecol Oncol; 2011 Sep; 122(3):505-8. PubMed ID: 21665253
[TBL] [Abstract][Full Text] [Related]
19. High Prevalence of Human Papillomavirus on Anal and Oral Samples from Men and Women with External Anogenital Warts: The HERCOLES Study.
Lisboa C; Santo I; Azevedo J; Azevedo L; Pista A; Dias C; Cunha MJ
Acta Derm Venereol; 2019 May; 99(6):557-563. PubMed ID: 30723872
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the epidemiology and morbidity burden associated with human papillomavirus in Israel: accounting for CIN1 and genital warts in addition to CIN2/3 and cervical cancer.
Shavit O; Raz R; Stein M; Chodick G; Schejter E; Ben-David Y; Cohen R; Arbel D; Shalev V
Appl Health Econ Health Policy; 2012 Mar; 10(2):87-97. PubMed ID: 22201263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
